15 August 2019
Interim Results
Interim results for the half year ended 30 June 2019…
Dividend Declaration
14 August 2019
Interim Management Statement for the six months ended 30 June 2019…
Calquence granted US Breakthrough Therapy Designation for chronic lymphocytic leukaemia…
Directorate Change
Interim Accounts 30th June 2019…
New corporate name for M&GPrudential at demerger…